Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deborah J. Wexler MD, MSc Associate Editor

Kathleen M. Dungan MD, MPH Advisory Board

Silvio E. Inzucchi MD Editor-in-Chief

See All Experts

featured

Published in Diabetes and

Journal Scan / Research · May 10, 2018

Metabolic Syndrome Is Associated With Lower Neurocognitive Function in Middle-Aged Hispanics/Latinos

Diabetes Care

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Silvio Inzucchi MD

Diabetes Care

Metabolic Syndrome and Neurocognition Among Diverse Middle-Aged and Older Hispanics/Latinos: HCHS/SOL Results

Diabetes Care 2018 May 01;[EPub Ahead of Print], HM González, W Tarraf, P Vásquez, AH Sanderlin, NI Rosenberg, S Davis, CJ Rodríguez, LC Gallo, B Thyagarajan, M Daviglus, T Khambaty, J Cai, N Schneiderman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Obesity, Metabolic Syndrome, and Prediabetes

Metabolic Syndrome Is Associated With Lower Neurocognitive Function in Middle-Aged Hispanics/Latinos

Additional Info

Metabolic Syndrome and Neurocognition Among Diverse Middle-Aged and Older Hispanics/Latinos: HCHS/SOL Results

Further Reading

Potential Off-Label Indication of Metformin for Ischaemic Stroke

GLP-1 Agonists Combined With GIP and/or GCG Agonists vs GLP-1 Agonists Alone for Weight Loss in Adults With Obesity Without Type 2 Diabetes

Effect of Long-Term Glycemic Burden on the Incidence of Diabetic Foot Ulcers

Weight Maintenance Using Cost-Effective Antiobesity Medications After 1 Year of GLP-1 Receptor Agonist Therapy

Trends in the Incidence of Young Adult–Onset Diabetes by Diabetes Type

Prognosis of Severe Hypoglycaemia and Diabetic Ketoacidosis in Adults Presenting to an Emergency Department

Perinatal Outcomes in Patients With Early vs Late Gestational Diabetes Mellitus Treated Between 24 and 28 Weeks of Gestation

Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth

Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes

Effect of Dapagliflozin on Renal Haemodynamics in Patients With Type 2 Diabetes and Glomerular Hyperfiltration

Effects of GLP-1 Receptor Agonists on Kidney and Cardiovascular Disease Outcomes

Recently Updated